ROKIT Healthcare Inc. (376900.KQ)
KOSDAQ · KRW · Healthcare · Medical Care Facilities
₩16,340 (+1.11%) as of
Key statistics
- Market cap
- 258.64B
- Dividend yield
- 0.00%
- 52-week range
- 15,430.00 – 153,800.00
- Revenue (TTM)
- 32.81B
- Profit margin
- -38.67%
- Volume
- 274.71k
About ROKIT Healthcare Inc.
ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell-derived whole extracellular matrix; EpiTem, a reconstructed human epidermis model; and anti-aging supplements, as well as operates a tissue bank. The company was formerly known as ROKIT Inc. and changed its name to ROKIT Healthcare Inc. in 2018. The company was incorporated in 2012 and is based in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Seoul, South Korea
- Employees
- 89
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.